Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: COA,ISO
Model Number: CAS 83480-29-9
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 working days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: 1Ton/Month
CAS No:: |
83480-29-9 |
Appearance: |
White To Off-white Crystalline Powder |
Molecular Formula:: |
C10H21NO7 |
Molecular Weight:: |
267.28 |
EINECS NO:: |
N/A |
MDL NO:: |
MFCD00865496 |
CAS No:: |
83480-29-9 |
Appearance: |
White To Off-white Crystalline Powder |
Molecular Formula:: |
C10H21NO7 |
Molecular Weight:: |
267.28 |
EINECS NO:: |
N/A |
MDL NO:: |
MFCD00865496 |
Product Description:
Product Name: Voglibose CAS NO: 83480-29-9
Synonyms:
3,4-Dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epiinositol;
5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol;
Chemical & Physical Properties:
Appearance : white to off-white crystalline powder
Assay :NLT99.0%
Boiling Point: 601.9℃ at 760 mmHg
Flash Point: 274.1℃
Melting Point: 162.0℃~163℃
Density:1.58 g/cm3
Refractive Index: 1.635
Vapor Pressure: 0mmHg at 25°C
PSA: 153.64000
LogP: -2.36
Solubility: Water (Slightly)
Category: Standards; Pharmaceutical/API Drug Impurities/Metabolites;
Safety Information:
RTECS: NM7524600
Safety Statements: S36/37
Risk Statements: R20/21/22
Hazard Codes: Xi
HS Code: 2933990090
Application: An α-Glucosidase inhibitor used as an antidiabetic.
D-epi-Inositol,3,4-dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl) wave of sugar is an oral fall blood sugar medicine, postprandial hyperglycemia can improve diabetes. Voglibose wave sugar applicability is wide and is not only applicable to middle-aged and old people with diabetes, for refractory patients with type 2 diabetes, patients with secondary failure to sulfonylureas, hyperlipidemia of diabetic patients, the combining cardio-cerebral blood tube disease of diabetic patients, merging, hyperinsulinemia have remarkable curative effect. Since this product does not stimulate the secretion of insulin, it can reduce the harmful effects of postpranational hyperinsulinemia, reduce insulin resistance, and be beneficial to the prevention and treatment of metabolic syndrome such as cardiovascular complications.
Our factory manufacture’s Voglibose CAS 83480-29-9, mature technology, stable output, quality assurance.
Delivery deadline: from stock
We can provide 2,3-Dideoxy-2-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-4-C-(hydroxymethyl)-epi-inositol COA, N-(1,3-Dihydroxy-2-propyl)valiolamine MOA, ROS, (1S,2S,3R,4S,5S)-5-[(1,3-Dihydroxy-2-propanyl)amino]-1-(hydroxymethyl)-1,2,3,4-cyclohexanetetrol MSDS and other support for you !
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.